MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 75 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $175,000 | -41.9% | 60,434 | -11.2% | 0.00% | -33.3% |
| Q4 2021 | $301,000 | -42.4% | 68,023 | -5.2% | 0.00% | -40.0% |
| Q3 2021 | $523,000 | -16.5% | 71,779 | +12.1% | 0.01% | -16.7% |
| Q2 2021 | $626,000 | -39.8% | 64,027 | -27.1% | 0.01% | -40.0% |
| Q1 2021 | $1,040,000 | +52.0% | 87,846 | +0.7% | 0.01% | +25.0% |
| Q4 2020 | $684,000 | +63.6% | 87,218 | +41.7% | 0.01% | +33.3% |
| Q3 2020 | $418,000 | +3.2% | 61,531 | +14.2% | 0.01% | +20.0% |
| Q2 2020 | $405,000 | -48.9% | 53,863 | -30.3% | 0.01% | -16.7% |
| Q3 2019 | $793,000 | -33.4% | 77,331 | -4.1% | 0.01% | -33.3% |
| Q2 2019 | $1,190,000 | – | 80,675 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $19,599,000 | 7.18% |
| TCG Crossover Management, LLC | 2,124,122 | $6,160,000 | 2.47% |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $10,082,000 | 1.28% |
| Deep Track Capital, LP | 5,359,000 | $15,541,000 | 1.00% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $3,393,000 | 0.82% |
| Casdin Capital, LLC | 2,773,468 | $8,043,000 | 0.36% |
| Alphabet Inc. | 3,339,138 | $9,684,000 | 0.31% |
| Bleichroeder LP | 484,400 | $1,405,000 | 0.25% |
| HARBOR CAPITAL ADVISORS, INC. | 151,599 | $440,000 | 0.21% |
| Integral Health Asset Management, LLC | 201,000 | $583,000 | 0.15% |